EMA Decision Due For Minoryx’s Leriglitazone & Apellis’ Pegcetacoplan

Conference room interior with big table and screen
The EMA's Human medicines committee will meet this week to decide which drugs should be approved in the EU • Source: Shutterstock

More from Approvals

More from Product Reviews